Georgiamune logo

Georgiamune Funding & Investors

Georgiamune is an immunotherapy company focused on oncology breakthroughs. The company employs next-generation immunotherapeutic and homeostatic therapies for cancer and autoimmune illnesses, allowing patients to recover quickly from cancer.

georgiamune.com

Total Amount Raised: $75,000,000

Georgiamune Funding Rounds

  • Series A

    $75,000,000

    Series A Investors

    Bioventures Investors
    Catalio Capital Management
    General Catalyst
    Parker Institute for Cancer Immunotherapy
    Alexandria Real Estate Equities
    Verition Fund Management
    Mubadala Capital Ventures
Funding info provided by Diffbot.